杂志简称：diabet metab synd ob
中文译名：《糖尿病、代谢综合征和肥胖征、靶标和治疗期刊》
收录属性：scie（2024版）, 英文期刊,
自引率：5.40%
投稿方向：医学、endocrinology & metabolism 内分泌学与代谢
SCI/E期刊基本信息
出版周期：不定期 地区：新西兰
中科院分区：3区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：OA期刊
国际标准刊号：ISSN1178-7007；EISSN1178-7007
杂志语言：英语
出版国家：新西兰
杂志官网 联系方式
出版地址：DOVE MEDICAL PRESS LTD,PO BOX 300-008,ALBANY,NEW ZEALAND,AUCKLAND,0752
杂志邮箱：
投稿网址：https://www.dovepress.com/submit-step-1.php
杂志官方网址：https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal
出版商网址：http://www.dovepress.com
杂志投稿要求
投稿须知【杂志社官方网站信息】
Aims and Scope
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is an international, peer-reviewed, open access journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings that lead to establishing new paradigms in the diagnosis, treatment or prevention of diabetes, metabolic syndrome, or obesity. The journal welcomes original research manuscripts, reviews, expert opinions, and commentaries relating to all aspects of obesity, diabetes, and metabolic syndrome.
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy will no longer consider meta-analyses for publication.
Specific topics covered by the journal include:
Pathophysiological processes underlying diabetes, obesity, or metabolic syndrome
Diagnosis and prognosis
Novel therapeutic strategies
Epidemiology, screening, and detection
Preventative measures
Management programs
Quality of life, adherence, and satisfaction
Comorbid disorders of the thyroid
Lipid metabolism disorders
The journal will consider case reports and study protocols only if they make a valuable and original contribution to the literature.
When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors’ own data through replication in an original sample.
Plant extract studies will only be considered if the active compound has been identified and validated.
Call For Papers
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is indexed online:
Pubmed and PubMed Central (Diabetes Metab Syndr Obes)
Science Citation Index Expanded (also known as SciSearch®)
Journal Citation Reports/Science Edition
Embase, from 2009 (Correct as at December 8, 2016)
Scopus, from 2009 (Correct as at December 8, 2016)
Directory of Open Access Journals (DOAJ)
OAIster – The Open Access Initiative
Journal Impact Factor: 3.168 (5 year impact 3.602)
What is the advantage to you of publishing in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy?
It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
Although Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy receives many papers, unlike most traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy has a quicker turnaround time than this. Generally peer review is complete within 4-7 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 9 weeks for a final decision.
Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution a publication processing fee.
PubMed Central
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is indexed on PubMed Central (title abbreviation: Diabetes Metab Syndr Obes). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page, you'll just need to supply the working title of your next paper and when you intend to submit by.
Yours sincerely
Professor Ming Zou
Editor-in-Chief
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Email: Editor-in-Chief
Author Guidelines
In this section you will find information on the entire submission process for Dovepress Journals. This includes how to format the paper, the language guidelines, referencing, the use of data & clinical trials and the acceptance process. These resources ensure the quality of the journal submissions and that the articles have the best chance of acceptance.
A summary of some of these sections are:
Manuscript preparation
This provides guidelines to the formatting requirements for a submission to Dove Medical Press, with instructions for formatting the document (margins, spacing, etc) and the text (spelling, abbreviations, etc).
Manuscript templates
The templates provided at this link can be used to ensure that the manuscript meets Dove specifications for formatting and structure of the text. The templates can be downloaded and saved to your computer.
Manuscript structure
This section contains a detailed breakdown of each section that the manuscript will contain, as well as all disclosures and acknowledgements that are required by Dove Medical Press. The section also includes criteria for inclusion in the author list.
Figures and tables
This contains specifications for the formatting of figures and tables, including technical requirements such as file types and naming, and graphic requirements such as font size and image resolution.
Clinical trial registration
This provides a clear definition that authors may use to determine if their study will be considered a clinical trial. The section sets out Dove’s requirements for registration of any clinical trial involving human subjects.
Reference style guidelines
In this section, authors will find style requirements for references and examples of how to reference different kinds of material, such as journal articles, books, etc.
Article type definitions
Authors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their paper during the submission process.
Invited reviews
This section explains Dove’s polices and procedures for commissioned reviews – please view this section if you have been approached by Dove to write a review paper.
Video abstracts
Here you will find technical specifications and editorial guidelines for authors wishing to include a video abstract in their submission. The section provides examples of video abstracts and instructions on how to submit a completed video.
Guide to submission status indicators
As your manuscript moves through the submission and publication processes, you will see a status indicator for the manuscript in the dashboard of your user account. This section explains each of the status indicators used by Dove Medical Press.
Proofs
This section provides guidelines for using Dove’s Online Correction Tool, which authors will use to check and amend manuscript proofs during the editorial process.
Does your manuscript need to have its English improved?
Here you will find a link to Dove’s recommended English-language editing service.
Updated 31 March 2021